Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.

Aarey Drugs & Pharmaceuticals Ltd.

Oct 31 BSE 94.45 (+ 1.84 1.99%)

Volume4181

Prev. Close
92.61

Open Price
91.02

Today's Low / High

90.85 94.45

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

31.30 94.50

Oct 31 NSE 94.97(+ 1.86 2.00%)

Volume61836

Prev. Close
93.11

Open Price
91.70

Today's Low / High

91.24 94.97

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.) 0.00 (0)

52 Wk Low / High

31.35 94.97

Standalone

(₹ in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	473.94	395.62	418.96	492.68	348.42
Total Operating Revenues	473.94	395.62	418.96	492.68	348.42

Other Income	9.81	6.96	2.73	2.75	7.01
Total Revenue	483.76	402.58	421.69	495.43	355.43

EXPENSES
Purchase Of Stock-In Trade	472.87	387.76	418.98	467.29	339.25
Changes In Inventories Of FG,WIP And Stock-In Trade	-10.80	-5.86	-15.14	4.78	-1.46
Employee Benefit Expenses	0.81	0.72	0.81	0.98	0.40
Finance Costs	4.66	4.38	2.87	2.00	2.43
Depreciation And Amortisation Expenses	1.94	1.70	1.57	1.99	0.92
Other Expenses	8.18	8.55	6.58	8.37	5.59
Total Expenses	477.65	397.24	415.68	485.40	347.13

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	6.10	5.34	6.01	10.03	8.30

Profit/Loss Before Tax	6.10	5.34	6.01	10.03	8.30

Tax Expenses-Continued Operations
Current Tax	1.40	1.32	1.78	2.61	1.66
Deferred Tax	0.17	-0.67	-0.04	-0.11	0.12
Tax For Earlier Years	0.51	0.00	0.50	0.98	0.00
Total Tax Expenses	2.08	0.66	2.24	3.48	1.79
Profit/Loss After Tax And Before ExtraOrdinary Items	4.02	4.68	3.77	6.54	6.51

Profit/Loss From Continuing Operations	4.02	4.68	3.77	6.54	6.51

Profit/Loss For The Period	4.02	4.68	3.77	6.54	6.51

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	1.42	1.67	1.49	2.72	2.79
Diluted EPS (Rs.)	1.42	1.67	1.49	2.72	2.79

Particulars	Mar 25
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00

INCOME
Revenue From Operations [Net]	473.94
Total Operating Revenues	473.94
Other Income	9.81
Total Revenue	483.76
EXPENSES
Purchase Of Stock-In Trade	472.87
Changes In Inventories Of FG,WIP And Stock-In Trade	-10.80
Employee Benefit Expenses	0.81
Finance Costs	4.66
Depreciation And Amortisation Expenses	1.94
Other Expenses	8.18
Total Expenses	477.65
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	6.10
Profit/Loss Before Tax	6.10
Tax Expenses-Continued Operations
Current Tax	1.40
Deferred Tax	0.17
Tax For Earlier Years	0.51
Total Tax Expenses	2.08
Profit/Loss After Tax And Before ExtraOrdinary Items	4.02
Profit/Loss From Continuing Operations	4.02
Profit/Loss For The Period	4.02
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	1.42
Diluted EPS (Rs.)	1.42